Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Work In Process (2022 - 2025)

Neuroone Medical Technologies' Work In Process history spans 4 years, with the latest figure at $135244.0 for Q4 2025.

  • For Q4 2025, Work In Process changed 0.01% year-over-year to $135244.0; the TTM value through Dec 2025 reached $135244.0, changed 0.01%, while the annual FY2025 figure was $130100.0, 32.37% down from the prior year.
  • Work In Process reached $135244.0 in Q4 2025 per NMTC's latest filing, up from $130100.0 in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $903554.0 in Q4 2022 to a low of $130100.0 in Q3 2025.
  • Average Work In Process over 4 years is $333259.7, with a median of $329122.5 recorded in 2025.
  • Peak YoY movement for Work In Process: tumbled 64.84% in 2024, then grew 28.95% in 2025.
  • A 4-year view of Work In Process shows it stood at $903554.0 in 2022, then plummeted by 57.43% to $384659.0 in 2023, then crashed by 64.84% to $135254.0 in 2024, then fell by 0.01% to $135244.0 in 2025.
  • Per Business Quant, the three most recent readings for NMTC's Work In Process are $135244.0 (Q4 2025), $130100.0 (Q3 2025), and $328368.0 (Q2 2025).